statistiche ricercatore

Continente	#
NA - Nord America	585
AS - Asia	403
EU - Europa	298
SA - Sud America	75
Continente sconosciuto - Info sul continente non disponibili	34
AF - Africa	5
OC - Oceania	2
Totale	1.402

Nazione	#
US - Stati Uniti d'America	549
IT - Italia	182
SG - Singapore	123
VN - Vietnam	75
CN - Cina	68
BR - Brasile	66
BD - Bangladesh	64
DE - Germania	28
HK - Hong Kong	26
CA - Canada	20
NL - Olanda	17
FR - Francia	11
GB - Regno Unito	11
IN - India	11
FI - Finlandia	10
JP - Giappone	9
UA - Ucraina	7
PL - Polonia	6
RU - Federazione Russa	6
SE - Svezia	5
PK - Pakistan	4
AR - Argentina	3
AT - Austria	3
CO - Colombia	3
ID - Indonesia	3
IQ - Iraq	3
MX - Messico	3
NI - Nicaragua	3
AU - Australia	2
CZ - Repubblica Ceca	2
ES - Italia	2
GT - Guatemala	2
HN - Honduras	2
JM - Giamaica	2
LT - Lituania	2
MY - Malesia	2
TR - Turchia	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BE - Belgio	1
BO - Bolivia	1
CH - Svizzera	1
CY - Cipro	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EC - Ecuador	1
EG - Egitto	1
ET - Etiopia	1
GD - Grenada	1
HU - Ungheria	1
JO - Giordania	1
KH - Cambogia	1
KW - Kuwait	1
KZ - Kazakistan	1
NP - Nepal	1
OM - Oman	1
PH - Filippine	1
QA - Qatar	1
RS - Serbia	1
SA - Arabia Saudita	1
SV - El Salvador	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.369

Nome	#
Case Report: A Case of Creutzfeldt-Jakob Heidenhain Variant Simulating PRES	248
Time perception in cerebellar and basal ganglia stroke patients	194
Cognition in Patients with Spinocerebellar Ataxia 1 (SCA1) and 2 (SCA2): A Neurophysiological and Neuropsychological Approach	172
Thalamic ventral-Oralis complex/rostral zona incerta deep brain stimulation for midline tremor	167
Miglustat as Disease-Modifying Therapy in a Patient with SCARB2-Related Action Myoclonus Renal Failure	120
Global improvement after deep brain stimulation in Parkinson's disease: Comparison between patient and clinician perspectives	118
Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study	92
Sex Differences in Spinocerebellar Ataxia Type 1: Clinical Presentation and Progression	84
Correction to: Sex Differences in Spinocerebellar Ataxia Type 1: Clinical Presentation and Progression (The Cerebellum, (2025), 24, 5, (127), 10.1007/s12311-025-01881-4)	54
Budget impact analysis of deep brain stimulation devices with different longevity in Parkinson's disease: insights from real-world data	47
Transanal Irrigation in patients with Parkinson's Disease and chronic constipation: rebalancing the Gut Microbiota?	39
Risk-Benefit Considerations in Deep Brain Stimulation Discontinuation for Late-Stage Parkinson's Disease	35
Deep Brain Stimulation for Cerebellar Ataxia: A Systematic Review on Indications, Targets and Outcomes	32
Totale	1.402

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	1	0	0	0	0	0	0	0	1	0	0	0	0
2023/2024	22	1	0	1	1	1	3	1	0	2	2	4	6
2024/2025	202	1	4	5	3	14	13	7	30	30	23	47	25
2025/2026	1.009	61	48	83	84	89	53	108	61	85	130	122	85
2026/2027	168	83	59	26	0	0	0	0	0	0	0	0	0
Totale													1.402

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara